Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.
Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor ...
Analysts fell to the sidelines weighing in on Pfizer (PFE – Research Report) and Sundrug Co (SDGCF – Research Report) with neutral ratings, indicating that the experts are nei ...
The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer yesterday and set a price target of $30.00. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and po ...
We recently published 10 Stocks Jim Cramer Talked About. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked ...
Pfizer shares fall nearly 5% in a month after weak 2026 guidance, sparking debate over buying the dip or staying cautious.
Pfizer Inc. (NYSE:PFE) is one of the best affordable stocks under $30. Pfizer Inc. (NYSE:PFE) announced on January 10 ...
Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an analysis of PFE stock now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results